Bluvit-D3

Quick links to important sections

Bluvit-D3

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bluvit-D3

Quick Facts

Property Description
Active ingredient Colecalciferol (Vitamin D3)
Form Oral tablet, soft gelatin capsule, or solution
Pharmacological class Vitamin D Analogue (Fat-soluble secosteroid)
Common role Calcium Homeostasis Regulator
Origin Natural precursor / Synthetic

What Type of Medicine is Bluvit-D3? (Identity and Classification)

Bluvit-D3 is a medicinal preparation containing the active ingredient Colecalciferol, which is chemically and biologically synonymous with Cholecalciferol or Vitamin D3. This essential substance is classified as a Vitamin D analogue, placing it within the domain of fat-soluble secosteroids. The compound functions as a prohormone, meaning the body must metabolically convert it into the potent hormone Calcitriol before it can exert its primary biological effects. This characteristic distinguishes it from active hormonal treatments. It is recognized as an essential nutrient due to its fundamental role in bone health, supporting the need for supplemental intake across patient groups.

Composition, Form, and Origin (Preparation and Physical Type)

The drug is formulated for oral administration and typically exists as a monotherapy product, with Colecalciferol as the sole active entity. Bluvit-D3 offers the active ingredient in multiple forms, often including a tablet, a soft gelatin capsule, or an oral solution. As a fat-soluble vitamin, the active Colecalciferol is generally dissolved in an oily base (such as medium-chain triglycerides) to ensure optimal absorption in the gastrointestinal tract, a formulation choice intended to enhance bioavailability. This preparation provides an exogenous source of the prohormone, necessary when sun exposure or dietary intake of this essential nutrient is insufficient.

General Purpose: Why is Colecalciferol Important? (High-Level Benefit)

The core purpose of supplying Colecalciferol is to support the body’s essential regulatory processes, specifically by maintaining calcium homeostasis and modulating phosphate metabolism. By ensuring that the body has the precursor necessary to manage the absorption and utilization of these essential minerals, Bluvit-D3 contributes directly to the maintenance of mineral balance. This function supports the critical process of bone mineralization, which is vital for the development and long-term structural integrity of the skeletal system, representing its primary, general health role.

Regulatory References

  1. Cholecalciferol (Vitamin D3) MedlinePlus Drug Information

What side effects are possible with Bluvit-D3?

Possible side effects and safety information

The safety profile of Colecalciferol (Bluvit-D3) is primarily defined by the risk of excessive vitamin D levels, which can lead to high calcium concentrations in the blood (Hypercalcaemia) and urine (Hypercalciuria). These effects are consistently documented in regulatory sources as the principal safety characteristics.


Officially Documented Adverse Reactions

Adverse reactions are classified based on frequency categories derived from regulatory clinical data:

  • Uncommon Adverse Reactions (Affecting less than 1 in 100 people):

    • Hypercalcaemia
    • Hypercalciuria
  • Rare Adverse Reactions (Affecting less than 1 in 1,000 people):

    • Pruritus (itching)
    • Rash
    • Urticaria (hives)

Serious Adverse Reactions and Toxicity

Symptoms indicative of acute or chronic hypercalcaemia, which may develop from prolonged, excessive intake, are documented and can affect multiple organ systems. Serious consequences, often related to toxicity, include the potential for Renal failure and Nephrocalcinosis (calcification of the kidneys). The regulatory labeling also notes that hypercalcaemia associated with intoxication has, in isolated cases, been fatal. Serious hypersensitivity reactions, such as anaphylaxis, are reported as rare.

General Safety and Restrictions

The medicine is subject to specific safety restrictions. It is contraindicated in individuals with pre-existing conditions of Hypercalcaemia, Hypercalciuria, Nephrolithiasis (kidney stones), or Severe renal impairment. Caution is advised for patients with sarcoidosis due to the increased risk of converting Colecalciferol to its active hormonal form. Overdose during pregnancy may also be linked to fetal developmental risks due to high maternal calcium levels.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Colecalciferol (Bluvit-D3) results in a serious, documented condition known as Hypervitaminosis D, which leads directly to hypercalcemia (abnormally high blood calcium levels).

Category Documented Manifestations
Common Symptoms Nausea, vomiting, loss of appetite (anorexia), abdominal pain, excessive thirst (polydipsia), excessive urination (polyuria), general weakness, and confusion.
Severe Outcomes The risk of progressive organ toxicity, including potentially irreversible renal failure due to nephrocalcinosis, cardiac arrhythmias, and generalized soft tissue calcification. In extreme cases, coma and death have been documented.

Immediate Emergency Actions

Regulatory documents explicitly mandate seeking immediate medical attention if symptoms of toxicity are suspected or persistent.

  • Urgent Medical Care: Individuals must seek immediate medical attention for persistent symptoms such as recurrent nausea, vomiting, or significant confusion.
  • Emergency Contact: Call emergency services immediately if the affected person collapses, has a seizure, or experiences difficulty breathing.

Management Notes

Treatment requires the immediate discontinuation of all Vitamin D and calcium supplements. Since no specific antidote is known, management is supportive, focusing on reversing the hypercalcemia. Procedures may include administering intravenous fluids and pharmacologic agents like bisphosphonates. Continuous monitoring of serum calcium, renal function, and ECG is required until levels normalize. Overdose must be avoided during pregnancy due to severe risks to the fetus.

Therapeutic Uses of Bluvit-D3

What Bluvit-D3 Treats: Main Uses and Benefits

Bluvit-D3 (cholecalciferol) is a therapeutic supplement applied across therapeutic domains where supportive management of symptoms is relevant. The preparation is used in situations involving recurrent or episodic manifestations linked to deficiency.

This supplement is commonly used across conditions presenting with systemic or localized discomfort, particularly addressing symptoms related to physical discomfort and functional strain. It supports patients during episodes of heightened discomfort and assists with maintaining stability when symptoms are more noticeable. This is relevant in clinical settings marked by heightened patient distress, especially during phases where supportive relief is needed.

Therapeutic Domains

Bluvit-D3 is applied in addressing conditions involving musculoskeletal symptoms, systemic imbalance, and symptoms that create noticeable physiological strain.


Quick Fact: Support for Muscular Discomfort


Regulatory References

  1. MedlinePlus Drug Information on Cholecalciferol

Eligibility and Restrictions for Use

Official Population Eligibility for Bluvit-D3 (Colecalciferol)

The population eligibility for using this medicine is determined by regulatory bodies based on the individual's existing mineral balance and organ function.

Populations for whom use is Contraindicated

Use of Bluvit-D3 is strictly contraindicated in individuals with pre-existing high blood calcium levels (hypercalcemia) or excessive levels of Vitamin D (hypervitaminosis D).

Non-eligibility also applies to patients with severe renal impairment, kidney stones (nephrolithiasis), or calcification of the kidney (nephrocalcinosis), as well as those with a known hypersensitivity to Colecalciferol or its excipients.

Populations Requiring Conditional Use

  • Condition-Specific Restrictions: Use requires caution and regular monitoring in patients with sarcoidosis or moderate renal impairment. These conditions may affect the metabolism of Colecalciferol and increase the risk of hypercalcemia.
  • Age-Related Eligibility: The medicine is generally permitted for use in adults, adolescents, and children, though some high-dose formulations are not recommended for children under 12 years of age. Older adults may require cautious use due to common age-related comorbidities.
  • Pregnancy and Lactation: Use at recommended daily doses is acceptable. However, regulatory bodies specify that high-dose or pharmacological use is not recommended or contraindicated unless strictly necessary to treat a confirmed deficiency.

What should I know about interactions with other medicines?

Bluvit-D3 Interactions with other medicines and products

This section describes documented interactions between the active ingredient in Bluvit-D3 (cholecalciferol) and other products, strictly based on authoritative regulatory and medical summaries.

Interaction Type Interacting Medicines/Classes Potential Effect
Reduced Absorption Bile Acid Sequestrants (e.g., Cholestyramine, Colestipol) and Mineral Oil/Laxatives These agents can bind to the cholecalciferol in the intestine, reducing the amount absorbed into the bloodstream.
Altered Metabolism Anticonvulsants/Enzyme Inducers (e.g., Phenytoin, Barbiturates) and Corticosteroids (Glucocorticoids) These medicines may speed up the breakdown (catabolism) of cholecalciferol in the body, potentially lowering its effectiveness. Corticosteroids may also reduce calcium absorption.
Increased Toxicity Risk Thiazide Diuretics (water pills) and Other Vitamin D Supplements (e.g., Calcitriol, Calcifediol) Concomitant use with Thiazide diuretics or other Vitamin D products significantly increases the risk of developing hypercalcemia (abnormally high blood calcium levels).
Increased Cardiac Risk Digitalis Glycosides (e.g., Digoxin) Hypercalcemia caused by high doses of Vitamin D can increase the risk of cardiac arrhythmias (irregular heart rhythms) in patients taking digitalis.

Restriction: The use of Bluvit-D3 with other Vitamin D preparations is generally advised against to prevent Vitamin D toxicity and severe hypercalcemia.

Timing-Based Condition: The label recommends administering bile acid sequestrants at a different time than Bluvit-D3 to mitigate the absorption-reducing effect.

Connection to the overall interaction profile: The interaction structure for cholecalciferol is defined by two primary clinical concerns: medications that reduce its availability through impaired absorption or increased metabolic breakdown, and medicines that increase the risk of calcium elevation. This requires monitoring and, in some cases, separated dosing or avoidance of specific combinations.

Mechanism of Action

How Bluvit-D3 Works

The mechanism begins with the Colecalciferol prohormone undergoing two sequential enzymatic hydroxylation steps in the liver and kidney. This metabolic activation yields Calcitriol (1,25-dihydroxyvitamin D3), the biologically active hormonal form. Calcitriol then acts as an agonist for the ubiquitous Vitamin D Receptor (VDR), a type of nuclear receptor found in target cells across multiple organ systems.

VDR activation initiates a genomic cascade where the receptor complex binds to DNA and actively modulates gene expression. This action produces system-level effects by upregulating transport proteins in the small intestine and kidney, which facilitate the absorption and reabsorption of calcium and phosphate. Additionally, the active hormone exerts a negative feedback loop on the Parathyroid Glands, suppressing the synthesis of Parathyroid Hormone (PTH).

This mechanism requires the enzyme 1-alpha-hydroxylase (CYP27B1), meaning the biological function is subject to functional constraint in conditions involving impaired renal health, which compromises Calcitriol production.

Dosage and Administration Information

How to Use Bluvit-D3

Bluvit-D3, a Colecalciferol preparation, is administered exclusively via the oral route as a capsule, tablet, or solution. The use of this preparation is structured into distinct dosing phases based on established protocols. To optimize absorption, which is critical for this fat-soluble compound, Bluvit-D3 must be taken concurrently with the main meal of the day or otherwise with food. Capsules and tablets are intended to be swallowed whole with water.


Administration Protocol and Dosing Regimens

Dosing Phase Typical Frequency Pattern Administration Principle
Initial Treatment Once weekly (high-potency unit) Used as a short course to correct serum 25( OH) D levels, requiring direct clinical supervision.
Maintenance Once daily (lower-potency unit) Follows the initial course and is part of a long-term plan to sustain adequate levels.

The administration protocol mandates that all dosing is individualized and titrated by a healthcare provider based on follow-up laboratory testing, which dictates the overall course duration. This adjustment logic ensures the regimen is responsive to measured blood levels. Furthermore, the use of high-potency forms is not recommended for children or adolescents due to the unit dose strength. Clinical considerations may also limit its use in specific patient groups, such as those with severe renal impairment, where administration is typically restricted.

Recent Clinical Evidence

Bluvit-D3: Recent Clinical Evidence

Bluvit-D3 is a formulation containing Cholecalciferol (Vitamin D3). Clinical evidence primarily focuses on the role of Vitamin D3 supplementation in addressing deficiency and supporting bone health, with ongoing research into its wider effects.

Key Areas of Research Focus

Health Area Study Findings Overview
Skeletal Health Vitamin D3 plays a critical role in promoting the absorption of calcium and phosphorus in the gut. Supplementation is established for the management of Vitamin D deficiency and associated conditions like rickets in children and osteomalacia (softening of bones) in adults. Studies suggest that adequate levels, alongside calcium, help maintain bone mineral density and may reduce fracture risk in older adults.
Immune Function Research suggests an association between Vitamin D status and immune system modulation. Inadequate levels have been linked to increased susceptibility to certain infections. However, the use of high-dose supplementation specifically to prevent or treat infections or autoimmune conditions remains an area of active investigation, with results from randomized controlled trials (RCTs) providing mixed evidence.
Comparative Efficacy Recent meta-analyses have compared the efficacy of Vitamin D2 (Ergocalciferol) and Vitamin D3 (Cholecalciferol). Findings often suggest that Vitamin D3 may be more effective at raising and maintaining the active form of vitamin D in the blood (25-hydroxyvitamin D) compared to Vitamin D2. Some studies have noted that Vitamin D2 supplementation may, in some cases, be associated with a decline in circulating D3 levels.

Tolerability and Safety Considerations

Studies confirm that Cholecalciferol is generally well tolerated when used according to medical guidance. The risk of toxicity and elevated calcium levels (hypercalcemia) is primarily associated with excessive intake, far exceeding recommended limits.

Frequently Asked Questions (FAQ)

Common questions about Bluvit-D3 (FAQ)


Q: Do I need to take Bluvit-D3 with food?

Official guidance suggests this administration method because Bluvit-D3 contains Colecalciferol (Vitamin D3), which is a fat-soluble substance. This compound requires the presence of fat from a meal to be properly absorbed into the body, as documented in official product information.


Q: Can pregnant women or those planning to conceive use Bluvit-D3?

Regulatory information indicates that the use of Colecalciferol at recommended daily doses is generally considered acceptable during pregnancy and lactation. However, regulatory bodies note that higher-strength formulations are typically reserved for confirmed deficiencies and require professional oversight.


Q: Is Bluvit-D3 suitable for children and teenagers?

Yes, Colecalciferol is permitted for use in children, adolescents, and adults, as documented in official prescribing information. However, specific high-dose formulations are generally not recommended for those under 12 years of age. The appropriate dosage is individualized and determined by a healthcare provider.


Q: Is Bluvit-D3 the same thing as regular Vitamin D3 supplements?

Bluvit-D3 contains the active ingredient Cholecalciferol (Vitamin D3). While this same ingredient is available in many over-the-counter supplements, high-strength versions of Colecalciferol may be classified as prescription-only medicines. These products are subject to specific regulatory review and are intended for supervised use.


Q: Does Bluvit-D3 require a prescription?

The need for a prescription depends on the specific strength and preparation. The active ingredient, Colecalciferol, is available in some lower-dose forms as an over-the-counter supplement. However, high-dose or specific formulations of Bluvit-D3 are classified as prescription-only medicines and require professional clinical supervision.


Q: What happens if I forget to take a dose of Bluvit-D3?

Regulatory patient information describes that a forgotten dose is generally taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Official guidance emphasizes that two doses should not be taken at the same time to compensate for a forgotten one.


Q: Is there a generic version of Bluvit-D3?

Yes, the active ingredient contained in Bluvit-D3, Colecalciferol, is widely available as a generic medication. The generic and branded products contain the same active therapeutic substance.


Q: Can I stop taking Bluvit-D3 suddenly?

Treatment with Colecalciferol is often prescribed as part of a long-term plan to maintain adequate Vitamin D levels in the body. Official patient information notes that stopping the medicine may cause deficiency symptoms to return and may affect bone health.


Q: Can I crush or split the Bluvit-D3 tablet/capsule?

Official regulatory information specifies that standard capsules and tablets should be swallowed whole with water. Crushing or splitting standard forms is not described as the intended method of administration in the official product information. Certain preparations, such as chewable tablets, have their own specific instructions.


Q: Is it true that Bluvit-D3 works better when taken in the morning?

Official administration guidelines state that Colecalciferol should be taken with the main meal of the day to promote its absorption. These guidelines do not specify a preferred time of day, indicating that the meal-based timing is the key consideration, not whether it is morning or evening.


Q: Can Bluvit-D3 affect blood test results?

Colecalciferol is used to directly regulate the levels of calcium and a form of Vitamin D (25-hydroxyvitamin D) in the blood. These substances are routinely monitored by a healthcare provider. Official patient information notes the importance of informing a healthcare provider of all medicines and supplements being taken, as they may influence test results.


Q: Why is Bluvit-D3 only available in certain forms (e.g., tablet, capsule)?

The formulation is dictated by the chemical properties of the medicine. Colecalciferol is a fat-soluble substance, and for optimal absorption and stability, official preparations are designed for oral use, such as soft gel capsules and oral solutions, where the active ingredient is typically dissolved in an oily base.


Q: How does Bluvit-D3 differ from other Vitamin D preparations?

Bluvit-D3 contains Cholecalciferol (Vitamin D3). Regulatory documents and studies suggest that Vitamin D3 may be more effective at raising and maintaining active vitamin D levels in the blood compared to the Vitamin D2 preparation known as Ergocalciferol.

How should Bluvit-D3 be stored and disposed of?

How to Store and Dispose of Bluvit-D3?

Regulatory agencies define specific conditions for storing Bluvit-D3 (cholecalciferol) to preserve its potency, as it is sensitive to degradation from the environment.

Requirement Type Official Regulatory Statement
Storage Conditions Store at room temperature and keep from freezing, away from excess heat and moisture (e.g., not in the bathroom).
Protection Protect from light and moisture; keep the medicine in the original container and ensure it is tightly closed.
Child Safety Keep out of the sight and reach of children, and always ensure safety caps are locked.
Disposal Ask your healthcare professional how you should dispose of any medicine you do not use. Do not flush the medication down the toilet or allow it to enter surface waters unless specifically instructed.

The drug must be disposed of once it is outdated or no longer needed. The preferred disposal method is through an approved medicine take-back program to ensure safe, controlled waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bluvit-D3 found in:

A-Z Index: